Fri Jul 25 23:18:58 SGT 2014  
SINGAPORE
GENITAL™
    Genital warts treatment, Singapore (SG)
HIV STD TESTING SINGAPORE™
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™

Summary

Genital warts treatment, Singapore (SG) | HIV STD TESTING SINGAPORE™ @singaporegenital_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital warts treatment, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute SD Bioline HIV Ag/Ab Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States
Fri, 25 Jul 2014 02:36:38 +0100 | CDC Morbidity and Mortality Weekly Report
(Source: CDC Morbidity and Mortality Weekly Report)

HPV Vax Uptake Remains Slow
Fri, 25 Jul 2014 02:13:12 +0100 | MedPage Today Public Health
(MedPage Today) -- Rates of vaccination against human papillomavirus continued to lag far behind national goals, including just a small bump in the rate since 2012, the CDC reported. (Source: MedPage Today Public Health)

CDC urges more teens to get HPV vaccine
Fri, 25 Jul 2014 01:39:26 +0100 | Health News: CBSNews.com
The Centers for Disease Control and Prevention says HPV vaccination rates for adolescent boys and girls in the United States remains unacceptably low, despite a slight increase since 2012. The human papillomavirus or HPV is the most common sexually transmitted infection. CBS News' David Begnaud reports. (Source: Health News: CBSNews.com)

HPV Vaccination Increasing, But Missed Opportunities Abound (FREE)
Fri, 25 Jul 2014 00:00:00 +0100 | Physician's First Watch current issue
By Amy Orciari Herman

Incomplete HPV vaccination may offer some protection
Thu, 24 Jul 2014 04:00:00 +0100 | EurekAlert! - Medicine and Health
(Boston University Medical Center) Minority women who received the Human Papillomavirus Vaccination even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. These findings appear in the journal Sexually Transmitted Diseases. (Source: EurekAlert! - Medicine and Health)

Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: A preliminary study
Thu, 24 Jul 2014 00:00:00 +0100 | The Laryngoscope
ConclusionRecent data suggest that less than 7% of the general population is HPV positive in the oral cavity. Our data suggest that the oral colonization rate is much higher in patients with AO‐RRP. Additionally, long‐term sexual partners of patients with RRP had a much higher rate of HPV positivity. These preliminary data may have implications for viral transmission and provide a framework for enhanced patient education as well as further investigation.

Associations between human papillomavirus and history of cancer among U.S. adults in the National Health and Nutrition Examination Survey (2003–2010)
Thu, 24 Jul 2014 00:00:00 +0100 | British Journal of Cancer AOP
Associations between human papillomavirus and history of cancer among U.S. adults in the National Health and Nutrition Examination Survey (2003–2010)

Rationale and design of the research project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): study protocol for a randomized controlled trial
Wed, 23 Jul 2014 00:00:00 +0100 | Trials
DiscussionSUCCESS is one of the first trials testing HPV self-sampling as a screening strategy among underserved minority women. If successful, HPV self-sampling may be an important option in community outreach programs aimed at reducing disparities in cervical cancer.Trial registration: Clinical Trials.gov # NCT02121548, registered April 21, 2014. (Source: Trials)

Fewer Vulvar HPV Infections After HPV16/18 VaccineFewer Vulvar HPV Infections After HPV16/18 Vaccine
Tue, 22 Jul 2014 11:34:55 +0100 | Medscape Medical News Headlines
Women who receive the bivalent HPV16/18 vaccine have lower rates of vulvar human papillomavirus (HPV) infection, according to results from the Costa Rica Vaccine Trial. Reuters Health Information (Source: Medscape Medical News Headlines)

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme
Tue, 22 Jul 2014 00:00:00 +0100 | BMC Infectious Diseases
Background: